A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2004
11/03/2004	CN1173718C Medicine for curing rheumatism arising from immune diease lupus erythematosus
11/03/2004	CN1173712C Compound preparation containing medicinal active bacteria and its preparation
11/03/2004	CN1173702C Glucocorticoid containing pharmaceutical inhalant powder and method for sterilizing the powder
11/03/2004	CN1173699C Medicine for treating lupus erythematosus
11/03/2004	CN1173697C Aniline disulfide derivatives for treating allergic diseases
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812236 Compounds useful in therapy
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812234 Ccr-2; inflammatory, immunoregulatory, allergic, and autoimmune disorders and diseases
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812209 Conjugate consisting of an active substance and a non-exogenous native protein
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6811796 Administering plant extracts; health food
11/02/2004	US6811787 Over-expressing homologous antigen vaccine and a method of making the same
11/02/2004	US6811784 Recombinant parainfluenza virus expression system and vaccines
11/02/2004	US6811782 Peptide composition as immunogen for the treatment of allergy
11/02/2004	US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2112014C Antiallergic composition for ophthalmic or nasal use
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
11/02/2004	CA2103454C Macrocyclic immunomodulators
10/2004
10/28/2004	WO2004092731A1 Element having bioactive substance fixed thereto
10/28/2004	WO2004092374A1 METHOD OF REGULATING ACTIVATION OF TRANSCRIPTIONAL FACTORS NF-AT, AP-1 AND NF-κB USING EFFECT OF ACTIVATING ADAPTOR PROTEIN 3BP2
10/28/2004	WO2004092206A1 Novel peptide, immunopotentiator and functional food and process for producing functional food
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092180A1 Flavone derivatives, process for producing them, and drugs containing the same
10/28/2004	WO2004092178A1 Benzoxepino-11-piperidylidene compounds and process for production thereof
10/28/2004	WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004	WO2004092147A1 M-stage kinesin inhibitor
10/28/2004	WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004	WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
10/28/2004	WO2004092118A2 2-propylidene-19-nor-vitamin d compounds
10/28/2004	WO2004091654A1 Vav inhibition in graft rejection
10/28/2004	WO2004091643A1 Agent for increasing granulocyte macrophage colony stimulating factor
10/28/2004	WO2004091630A1 Remedies for diseases to be applied to eye
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004091610A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004	WO2004080461A3 Stable pharmaceutical compositions of desloratadine
10/28/2004	WO2004071418A3 Compounds for the treatment of systemic lupus erythematosus
10/28/2004	WO2004058791A3 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
10/28/2004	WO2004012817A3 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
10/28/2004	WO2003105908A3 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003087126A3 Heteroclitic analogs and related methods
10/28/2004	WO2003037371A3 Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents
10/28/2004	WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/28/2004	US20040215292 Photodynamic treatment of targeted cells
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004	US20040214897 Uses for 2-amino-2-propane-1,3-diols
10/28/2004	US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004	US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/28/2004	US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders
10/28/2004	US20040214864 Novel compounds
10/28/2004	US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer
10/28/2004	US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens
10/28/2004	US20040214821 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/28/2004	US20040214820 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
10/28/2004	US20040214815 Therapeutic compounds
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214803 1,25-dihydroxy-16,23Z-diene-26,27-hexafluoro-19-nor vitamin D3; for preventing and/or treating allograft rejection
10/28/2004	US20040214794 perorally or rectally administering an effective amount of a lipopolysaccharide isolated from Escherichia coli
10/28/2004	US20040214789 Therapeutics
10/28/2004	US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug
10/28/2004	US20040214775 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
10/28/2004	US20040214762 administering serine protease inhibitors and optionally in combination with substance P or peptide hormones, for prophylaxis of nervous system disorders, autoimmune disorders and tissue regeneration processes, such as wound healing
10/28/2004	US20040214761 induction of apoptosis in tumor cells by administering monoclonal antibodies
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214756 administering mixtures of antithrombin and interleukins, tumor necrosis factors or enzyme inhibitors, for prophylaxis of infections
10/28/2004	US20040214290 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
10/28/2004	US20040214231 Methods of testing for allergic diseases,and therapeutic agents for treating same
10/28/2004	US20040214192 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis
10/28/2004	US20040214190 Mammalian c-type lectins
10/28/2004	US20040214172 Sheeplice, bovicola ovis, allergen treatment
10/28/2004	US20040213862 comprising Morinda citrifolia fruit juice; treatment of allergies or asthma; increasing glucose production
10/28/2004	US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
10/28/2004	US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors
10/28/2004	US20040213797 Conjugates for the modulation of immune responses
10/28/2004	US20040213795 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer
10/28/2004	US20040213784 bone marrow transplant (BMT), peripheral blood stem cell (PBSC); use of anti-CD20 monoclonal antibody (RITUXAN) as a purging agent during treatment of B-cell-related malignancies, e.g., B-cell lymphomas or leukemias; enhance engraftment and/or prevent disease relapse
10/28/2004	CA2718356A1 High concentration antibody and protein formulations
10/28/2004	CA2527175A1 Remedies for diseases to be applied to eye
10/28/2004	CA2522802A1 Biologically active substance-immobilized device
10/28/2004	CA2522104A1 Vav inhibition in graft rejection
10/28/2004	CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	CA2521841A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/28/2004	CA2521831A1 Benzoxepino-11-piperidylidene compounds and process for production thereof
10/28/2004	CA2521826A1 Recombinant il-9 antibodies and uses thereof
10/27/2004	EP1471055A1 6-phenylpyridyl-2-amine derivatives
10/27/2004	EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
10/27/2004	EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
10/27/2004	EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
10/27/2004	EP1470249A2 Effectors of innate immunity
10/27/2004	EP1470239A2 Psoriasin expression by breast epithelial cells
10/27/2004	EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes
10/27/2004	EP1470157A2 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof

1 ... 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 ... 1172